Kymera Therapeutics, Inc.
KYMR
Rang în acțiuni
#2203
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Preț acțiune
$113.05
Capitalizare de piață
$9.30B
Schimbare (1 zi)
4.60%
Schimbare (1 an)
86.85%
Țară
US
Tranzacționează Kymera Therapeutics, Inc. (KYMR)
Categorie
Healthcare
Raport P/S pentru Kymera Therapeutics, Inc. (KYMR)
Raport P/S la data de October 2026 TTM: 83.70
Conform celor mai recente rapoarte financiare și prețului acțiunilor Kymera Therapeutics, Inc., raportul P/S actual (TTM) este 83.70. La sfârșitul anului 2023, compania avea un P/S de 18.91.
Istoricul raportului P/S pentru Kymera Therapeutics, Inc. din 2018 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 83.70 | 30.50% |
| 2024 | 64.14 | 239.21% |
| 2023 | 18.91 | -34.23% |
| 2022 | 28.75 | -31.28% |
| 2021 | 41.83 | -48.46% |
| 2020 | 81.17 | -83.92% |
| 2019 | 504.79 | 0.00% |
| 2018 | 0.00 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| 10.02 | -88.03% |
US
|
|
| 40.55 | -51.55% |
US
|
|
| 3.96 | -95.27% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | -87.88% |
NL
|
